|
C5ORF28 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.13320000050265E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.89460000027597E-07 |
| Normal-vs-Stage2 |
2.989600E-02 |
| Normal-vs-Stage3 |
1.760720E-04 |
| Normal-vs-Stage4 |
3.32189999951993E-07 |
| Stage1-vs-Stage2 |
2.460600E-01 |
| Stage1-vs-Stage3 |
5.235000E-01 |
| Stage1-vs-Stage4 |
6.091400E-01 |
| Stage2-vs-Stage3 |
4.507800E-01 |
| Stage2-vs-Stage4 |
1.749960E-01 |
| Stage3-vs-Stage4 |
3.387600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.45169998034112E-09 |
| Normal-vs-AfricanAmerican |
4.38930000001836E-06 |
| Normal-vs-Asian |
6.093000E-01 |
| Caucasian-vs-AfricanAmerican |
8.665000E-01 |
| Caucasian-vs-Asian |
2.028800E-01 |
| AfricanAmerican-vs-Asian |
1.989170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.78970000000545E-06 |
| Normal-vs-Female |
5.46480000140903E-08 |
| Male-vs-Female |
4.790200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.825320E-04 |
| Normal-vs-Age(41-60Yrs) |
9.03850000399942E-08 |
| Normal-vs-Age(61-80Yrs) |
5.35139999979783E-07 |
| Normal-vs-Age(81-100Yrs) |
1.348130E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.682400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.573600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.247200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.394400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.125600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.031000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.280700E-03 |
| Normal-vs-Grade 2 |
2.001800E-04 |
| Normal-vs-Grade 3 |
6.15120000047042E-07 |
| Normal-vs-Grade 4 |
2.36149999555124E-08 |
| Grade 1-vs-Grade 2 |
3.766800E-01 |
| Grade 1-vs-Grade 3 |
3.571400E-01 |
| Grade 1-vs-Grade 4 |
9.722600E-01 |
| Grade 2-vs-Grade 3 |
2.364400E-01 |
| Grade 2-vs-Grade 4 |
1.369720E-02 |
| Grade 3-vs-Grade 4 |
6.852300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.45780000002394E-06 |
| Normal-vs-ccB subtype |
1.019600E-04 |
| ccA subtype-vs-ccB subtype |
8.537400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.12069999999676E-05 |
| Normal-vs-N1 |
1.568080E-02 |
| N0-vs-N1 |
8.810000E-01 |
|
|
